Kit Exon 8 Mutation
Kit Exon 8 Mutation - Related Videos
06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
0 Views •
2026
This video case report demonstrates the unique management of a duodenal gastrointestinal stromal tumor with a rare, understudied, exon 8 KIT mutation. Neoadjuvant therapy resulted in a 30% reduction in tumor size, making the patient a candidate for a robotic-assisted duodenal sleeve resection instead of the more morbid pancreaticoduodenectomy.
11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
0 Views •
Cited by 64 •
2013
We describe the preparation of barcoded DNA libraries and subsequent hybridization-based exon capture for detection of key cancer-associated mutations in clinical tumor specimens by massively parallel "next generation" sequencing. Targeted exon sequencing offers the benefits of high throughput, low cost, and deep sequence coverage, thus yielding high sensitivity for detecting low frequency mutations.
02:32
Exon Recombination
0 Views •
2021
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. Exon shuffling follows “splice frame rules.” Each exon has three reading...
10:30
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
0 Views •
Cited by 23 •
2016
Exon skipping is currently a most promising therapeutic option for Duchenne muscular dystrophy (DMD). To expand the applicability for DMD patients and to optimize the stability/function of the resulting truncated dystrophin proteins, a multi-exon skipping approach using cocktail antisense oligonucleotides was developed and we demonstrated systemic dystrophin rescue in a dog model.
05:51
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
0 Views •
Cited by 11 •
2011
Molecular genetic strategy for finding de novo mutations causing common disorders such as autism and schizophrenia.
FAQs
The exon’s location matters because it encodes part of KIT’s extracellular domain, so a sequence change there can modify receptor function before signals are transmitted inside the cell. This altered behavior may contribute to abnormal growth signaling, especially when receptor activity occurs without the usual ligand-dependent trigger.
Here, ligand-independent activation refers to KIT signaling that does not require the normal activating ligand. For an exon 8 variant, this possibility is important because persistent or inappropriately initiated receptor activity could continuously engage pathways controlling cell survival, proliferation, or differentiation, contributing to abnormal cellular behavior.
These pathways connect a molecular finding to disease behavior. If altered KIT function changes signaling that regulates survival, proliferation, or differentiation, the variant may help explain growth-related properties of a neoplasm. Studying this connection provides biological context for interpreting the mutation rather than treating the sequence change as an isolated laboratory result.
Testing is used as a molecular classification tool rather than only as a yes-or-no genetic result. A laboratory finding can help place a tumor or hematologic malignancy within a KIT-associated molecular context, then support characterization of its biology, prognosis, and relevance to targeted-therapy evaluation.
In gastrointestinal stromal tumors, acute myeloid leukemia, and other KIT-associated neoplasms, identifying an exon 8 alteration can add molecular detail to disease assessment. The significance is not limited to one cancer type: the result may support classification and help frame KIT-related biology across distinct clinical settings.
A reported KIT exon 8 mutation can inform three related questions: what molecular features characterize the disease, whether the finding has prognostic relevance, and whether a targeted treatment should be selected or evaluated. These uses connect genetic testing with clinical and research decisions during assessment of KIT-associated disease.